Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
8.02
+0.25 (3.22%)
At close: Mar 9, 2026, 4:00 PM EDT
8.02
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
Journey Medical Revenue
Journey Medical had revenue of $17.63M in the quarter ending September 30, 2025, with 20.52% growth. This brings the company's revenue in the last twelve months to $59.40M, up 2.82% year-over-year. In the year 2024, Journey Medical had annual revenue of $56.13M, down -29.11%.
Revenue (ttm)
$59.40M
Revenue Growth
+2.82%
P/S Ratio
4.34
Revenue / Employee
$1,448,756
Employees
41
Market Cap
265.39M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Emergent BioSolutions | 742.90M |
| Organogenesis Holdings | 564.17M |
| Evolus | 297.18M |
| Aurora Cannabis | 272.13M |
| Akebia Therapeutics | 236.20M |
| Organigram Global | 204.21M |
| Canopy Growth | 203.04M |
| SIGA Technologies | 172.25M |
DERM News
- 6 weeks ago - Journey Medical: Emrosi Is Winning, But The Stock Hasn't Noticed - Seeking Alpha
- 3 months ago - Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology - GlobeNewsWire
- 4 months ago - Journey Medical Corporation (DERM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 4 months ago - Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 - GlobeNewsWire
- 4 months ago - Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference - GlobeNewsWire
- 5 months ago - Journey Medical Corporation to Participate in October 2025 Investor Conferences - GlobeNewsWire
- 6 months ago - Journey Medical: EMROSI's Ramp Puts Profitability On The Horizon - Seeking Alpha